Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX

被引：16
|
作者：
Barnes, C. [1 ]
Davis, A. [1 ]
Furmedge, J. [1 ]
Egan, B. [2 ]
Donnan, L. [3 ]
Monagle, P. [1 ]
机构：
[1] Royal Childrens Hosp, Henry Ekert Haemophilia Treatment Ctr, Melbourne, Vic 3052, Australia
[2] Royal Childrens Hosp, Dept Physiotherapy, Melbourne, Vic 3052, Australia
[3] Royal Childrens Hosp, Dept Orthoped, Melbourne, Vic 3052, Australia
来源：
HAEMOPHILIA | 2010年 / 16卷 / 05期
关键词：
D O I：
10.1111/j.1365-2516.2007.01446.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：840 / 841
页数：2
相关论文
共 50 条
  • [1] Factor IX inhibitors and anaphylaxis in haemophilia B
    Warrier, I
    Ewenstein, BM
    Koerper, MA
    Shapiro, A
    Key, N
    Dimichele, D
    Miller, RT
    Pasi, J
    Rivard, GE
    Sommer, SS
    Bergmann, F
    Lusher, JM
    HAEMOPHILIA, 1996, 2 (04) : 259 - 260
  • [2] Immune tolerance induction using Fc-fusion-protein recombinant factor IX in severe haemophilia B
    Amid, Ali
    Perkins, Heather
    Gauthier, Julie
    Bonnefoy, Arnaud
    Carcao, Manuel
    Rivard, Georges-etienne
    Klaassen, Robert J.
    HAEMOPHILIA, 2021, 27 (06) : E776 - E779
  • [3] Immune Tolerance Induction in A Patient with Severe Haemophilia A and Factor VIII Inhibitors
    Freiria Alberte, C.
    Legarda, M.
    Cid, A. R.
    Guarin, A. P.
    Querol Fuentes, F.
    Bonanad Boix, S.
    Haya Guaita, S.
    HAEMOPHILIA, 2017, 23 : 47 - 48
  • [4] Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure
    Barnes, C
    Rudzki, Z
    Ekert, H
    HAEMOPHILIA, 2000, 6 (06) : 693 - 695
  • [5] Eradication of factor IX neutralizing and anaphylactic inhibitors in a patient with severe haemophilia B using cyclophosphamide immune suppression and factor IX desensitization
    Greenmyer, Jacob R.
    Grindeland, Carlina J.
    Kobrinsky, Nathan L.
    HAEMOPHILIA, 2020, 26 (02) : E51 - E54
  • [6] Immune Tolerance Induction (ITI) With Factor IX and Combined Immunosuppressive Therapy in two Patients With Severe Haemophilia B, Longstanding Inhibitors and Previous Allergic Reactions
    Holstein, K.
    Voigtlaender, M.
    Dicke, C.
    Langer, F.
    HAEMOPHILIA, 2017, 23 : 93 - 93
  • [7] Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis
    Alexander, Sarah
    Hopewell, Steve
    Hunter, Susan
    Chouksey, Akhilesh
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (01) : 93 - 95
  • [8] Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: is there a role for Rituximab® and desensitization therapy?
    Gamerman, S.
    Singh, A. M.
    Makhija, M.
    Sharathkumar, A.
    HAEMOPHILIA, 2013, 19 (06) : E382 - E385
  • [9] The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate
    Chuansumrit, Ampaiwan
    Moonsup, Yingwan
    Sirachainan, Nongnuch
    Benjaponpitak, Suwat
    Suebsangad, Atchara
    Wongwerawattanakoon, Pakawan
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (03) : 208 - 211
  • [10] Continuous infusion of factor IX concentrate for immune tolerance induction (ITI) in two patients with haemophilia B
    Tengborn, L
    Berntorp, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS213 - PS213
12345